| Application number | Title of the application | Filing Date | Status |
|---|
| 09/786015 | High-affinity antibodies | Apr 8, 2001 | Abandoned |
Array
(
[id] => 6633660
[patent_doc_number] => 20030211498
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-13
[patent_title] => 'Tumor markers in ovarian cancer'
[patent_app_type] => new
[patent_app_number] => 10/257021
[patent_app_country] => US
[patent_app_date] => 2002-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15885
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20030211498.pdf
[firstpage_image] =>[orig_patent_app_number] => 10257021
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/257021 | Tumor markers in ovarian cancer | Apr 2, 2001 | Issued |
Array
(
[id] => 5935447
[patent_doc_number] => 20020061310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-23
[patent_title] => 'Compositions and methods for dendritic cell-based immunotherapy'
[patent_app_type] => new
[patent_app_number] => 09/821883
[patent_app_country] => US
[patent_app_date] => 2001-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14236
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0061/20020061310.pdf
[firstpage_image] =>[orig_patent_app_number] => 09821883
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/821883 | Compositions and methods for dendritic cell-based immunotherapy | Mar 29, 2001 | Issued |
Array
(
[id] => 5846087
[patent_doc_number] => 20020132979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-19
[patent_title] => 'Compositions and methods for inhibition of cancer invasion and angiogenesis'
[patent_app_type] => new
[patent_app_number] => 09/823277
[patent_app_country] => US
[patent_app_date] => 2001-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 16569
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20020132979.pdf
[firstpage_image] =>[orig_patent_app_number] => 09823277
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/823277 | Compositions and methods for inhibition of cancer invasion and angiogenesis | Mar 29, 2001 | Abandoned |
Array
(
[id] => 1002293
[patent_doc_number] => 06908747
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-06-21
[patent_title] => 'Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 09/820003
[patent_app_country] => US
[patent_app_date] => 2001-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 21123
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/908/06908747.pdf
[firstpage_image] =>[orig_patent_app_number] => 09820003
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/820003 | Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof | Mar 28, 2001 | Issued |
| 09/806125 | Agents for retarding change of hormone-dependent cancer into hormone-independent cancer | Mar 27, 2001 | Abandoned |
Array
(
[id] => 1043586
[patent_doc_number] => 06867019
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-03-15
[patent_title] => 'Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 09/817199
[patent_app_country] => US
[patent_app_date] => 2001-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 20663
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/867/06867019.pdf
[firstpage_image] =>[orig_patent_app_number] => 09817199
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/817199 | Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof | Mar 26, 2001 | Issued |
Array
(
[id] => 6157692
[patent_doc_number] => 20020146758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-10
[patent_title] => 'Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/817198
[patent_app_country] => US
[patent_app_date] => 2001-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 20798
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20020146758.pdf
[firstpage_image] =>[orig_patent_app_number] => 09817198
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/817198 | Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof | Mar 26, 2001 | Issued |
Array
(
[id] => 6847352
[patent_doc_number] => 20030166519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Novel polynucleotides and polypeptides and uses therefor'
[patent_app_type] => new
[patent_app_number] => 09/815453
[patent_app_country] => US
[patent_app_date] => 2001-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 32026
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 29
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166519.pdf
[firstpage_image] =>[orig_patent_app_number] => 09815453
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/815453 | Novel polynucleotides and polypeptides and uses therefor | Mar 21, 2001 | Abandoned |
Array
(
[id] => 6015853
[patent_doc_number] => 20020102641
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-01
[patent_title] => 'Oncogenic osteomalacia-related gene 1'
[patent_app_type] => new
[patent_app_number] => 09/814550
[patent_app_country] => US
[patent_app_date] => 2001-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 17543
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20020102641.pdf
[firstpage_image] =>[orig_patent_app_number] => 09814550
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/814550 | Oncogenic osteomalacia-related gene 1 | Mar 21, 2001 | Abandoned |
Array
(
[id] => 6846664
[patent_doc_number] => 20030165831
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer'
[patent_app_type] => new
[patent_app_number] => 09/814353
[patent_app_country] => US
[patent_app_date] => 2001-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36963
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20030165831.pdf
[firstpage_image] =>[orig_patent_app_number] => 09814353
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/814353 | Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer | Mar 20, 2001 | Abandoned |
Array
(
[id] => 1178835
[patent_doc_number] => 06743898
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-06-01
[patent_title] => 'Monoclonal antibodies that suppress B cell growth and/or differentiation'
[patent_app_type] => B2
[patent_app_number] => 09/808847
[patent_app_country] => US
[patent_app_date] => 2001-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 12
[patent_no_of_words] => 7467
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/743/06743898.pdf
[firstpage_image] =>[orig_patent_app_number] => 09808847
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/808847 | Monoclonal antibodies that suppress B cell growth and/or differentiation | Mar 14, 2001 | Issued |
Array
(
[id] => 6141540
[patent_doc_number] => 20020001805
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-03
[patent_title] => 'Immunogenic ovarian cancer genes'
[patent_app_type] => new
[patent_app_number] => 09/805177
[patent_app_country] => US
[patent_app_date] => 2001-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15790
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0001/20020001805.pdf
[firstpage_image] =>[orig_patent_app_number] => 09805177
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/805177 | Immunogenic ovarian cancer genes | Mar 13, 2001 | Abandoned |
Array
(
[id] => 676453
[patent_doc_number] => 07087715
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-08-08
[patent_title] => 'Human paris-1 antigen and nucleic acids: diagnostic and therapeutic uses'
[patent_app_type] => utility
[patent_app_number] => 10/221658
[patent_app_country] => US
[patent_app_date] => 2001-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 23160
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/087/07087715.pdf
[firstpage_image] =>[orig_patent_app_number] => 10221658
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/221658 | Human paris-1 antigen and nucleic acids: diagnostic and therapeutic uses | Mar 12, 2001 | Issued |
Array
(
[id] => 6358456
[patent_doc_number] => 20020058292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-16
[patent_title] => 'Ovarian tumor antigen and methods of use therefor'
[patent_app_type] => new
[patent_app_number] => 09/802124
[patent_app_country] => US
[patent_app_date] => 2001-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 18371
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20020058292.pdf
[firstpage_image] =>[orig_patent_app_number] => 09802124
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/802124 | Ovarian tumor antigen and methods of use therefor | Mar 6, 2001 | Abandoned |
Array
(
[id] => 1188761
[patent_doc_number] => 06733992
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-05-11
[patent_title] => 'Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof'
[patent_app_type] => B2
[patent_app_number] => 09/788654
[patent_app_country] => US
[patent_app_date] => 2001-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 23670
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/733/06733992.pdf
[firstpage_image] =>[orig_patent_app_number] => 09788654
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/788654 | Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof | Feb 20, 2001 | Issued |
| 09/781844 | Method and compositions for treating hepatocellular cancer | Feb 11, 2001 | Abandoned |
Array
(
[id] => 1438334
[patent_doc_number] => 06494664
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-17
[patent_title] => 'Vehicle cargo loading and unloading system'
[patent_app_type] => B1
[patent_app_number] => 09/775444
[patent_app_country] => US
[patent_app_date] => 2001-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 5
[patent_no_of_words] => 3313
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 323
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/494/06494664.pdf
[firstpage_image] =>[orig_patent_app_number] => 09775444
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/775444 | Vehicle cargo loading and unloading system | Feb 1, 2001 | Issued |
Array
(
[id] => 5936591
[patent_doc_number] => 20020061846
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-23
[patent_title] => 'Methods for preventing or attenuating pathoangiogenic conditions'
[patent_app_type] => new
[patent_app_number] => 09/776865
[patent_app_country] => US
[patent_app_date] => 2001-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12394
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0061/20020061846.pdf
[firstpage_image] =>[orig_patent_app_number] => 09776865
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/776865 | Methods for preventing or attenuating pathoangiogenic conditions | Feb 1, 2001 | Abandoned |
Array
(
[id] => 5950800
[patent_doc_number] => 20020006413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-17
[patent_title] => 'Genetically engineered tumor cell vaccines'
[patent_app_type] => new
[patent_app_number] => 09/772102
[patent_app_country] => US
[patent_app_date] => 2001-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 26022
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0006/20020006413.pdf
[firstpage_image] =>[orig_patent_app_number] => 09772102
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/772102 | Genetically engineered tumor cell vaccines | Jan 25, 2001 | Abandoned |
